OpportunityTitle: Ensuring the Quality of Molecular Genetic Testing in Healthcare Delivery Systems:  Promoting Effective Reporting and Use of Test Results for Clinical Decision Making
AdditionalInformationOnEligibility: Eligible applicants that can apply for this funding opportunity are listed below:  Nonprofit with 501C3 IRS status (other than institution of higher education)  &#149;Nonprofit without 501C3 IRS status (other than institution of higher education)  &#149;Universities  &#149;Colleges  &#149;Research institutions  &#149;Hospitals  &#149;Community-based organizations  &#149;Faith-based organizations  &#149;Federally recognized or state-recognized American Indian/Alaska Native tribal governments  &#149;American Indian/Alaska native tribally designated organizations  &#149;Alaska Native health corporations  &#149;Urban Indian health organizations  &#149;Tribal epidemiology centers  State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau)  Political subdivisions of States (in consultation with States)   A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application.  If applying as a bona fide agent of a state or local government, a letter from the state or local government as documentation of the status is required.  Attach with &#147;Other Attachment Forms&#148; when submitting via www.grants.gov.
Description: Purpose: The intent of the RFA is to provide funding for the design and implementation of a pilot project to evaluate the previously developed clinician-friendly molecular genetic test report format and other principles established in previous work supported by the CDC (J Mol Diagn 2009;11:162-171; J Mol Diagn 2008:10:459-468) to determine whether changes in clinical and laboratory practices are likely to improve the quality of patient care within a targeted healthcare delivery system. A healthcare delivery system can refer to a fee-for-service network, health maintenance organization, academic medical center with outreach clinics, or similar entities with a diverse but defined patient population. Specified genetic conditions for which clinical molecular testing is available will be chosen as models in carrying out the work proposed.
GrantorContactEmailDescription: PGOTIM@cdc.gov
GrantorContactText: Center for Disease Control and Prevention &lt;br/&gt;Procurement and Grants Office &lt;br/&gt;TIMS &lt;br/&gt;Phone 770-488-2700